ESTA · Establishment Labs Holdings Inc.
$93.42
+0.84 (+0.91%)
At close · Jul 20
Market Cap
$2.75B
Shares
29.43M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$211.08M
+27.1%
FY2025
Net Income
-$51.06M
+39.6%
FY2025
Gross Margin
69.32%
+3.4pp
FY2025
Operating Margin
-18.48%
+11.6pp
FY2025
Diluted EPS
-$1.72
+42.7%
FY2025
Operating Cash Flow
-$50.89M
+13%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| $266.5M – $268.5M | $229.58M | $211.08MG | $166.03M | $165.15M | $161.7M | $126.68M | $84.68M | $89.57M | $61.21M | |
| — | $68.74M | $64.77M | $56.5M | $58.17M | $55.11M | $41.28M | $32.17M | $34.7M | $25.09M | |
| — | $160.84M | $146.31M | $109.53M | $106.98M | $106.6M | $85.4M | $52.5M | $54.86M | $36.12M | |
| — | — | 69.32% | 65.97% | 64.78% | 65.92% | 67.42% | 62% | 61.25% | 59.01% | |
| — | $20.43M | $20.25M | $19.71M | $26.43M | $20.27M | $18.32M | $13.79M | $14.99M | $12.69M | |
| — | $168.98M | $165.07M | $139.81M | $145.58M | $125.98M | $92.23M | $66.63M | $70.81M | $47.3M | |
| — | $3.3M | $3.3M | $2.1M | $1.2M | $1.2M | $1.2M | $900K | $600K | $600K | |
| — | $6.2M | $6.2M | $4.7M | $2.8M | — | — | — | — | — | |
| — | $189.41M | $185.32M | $159.51M | $172M | $146.25M | $110.54M | $80.42M | $85.8M | $59.98M | |
| — | -$28.57M | -$39.01M | -$49.99M | -$65.03M | -$39.66M | -$25.14M | -$27.92M | -$30.94M | -$23.86M | |
| — | — | -18.48% | -30.11% | -39.37% | -24.53% | -19.84% | -32.97% | -34.55% | -38.99% | |
| — | -$22.37M | -$32.81M | -$45.29M | -$62.23M | — | — | — | — | — | |
| — | $26.49M | $25.26M | $20.83M | $15.39M | $11.76M | $9.06M | $9.37M | $8.7M | $8.81M | |
| — | $199K | $423K | $1.48M | $1.02M | $87K | $23K | $15K | $4000 | $16K | |
| — | $3.55M | $5.82M | -$15.29M | $816K | -$3.18M | -$6.27M | -$2.68M | -$1.21M | -$2.39M | |
| — | -$51.32M | -$58.02M | -$84.63M | -$78.58M | -$72.82M | -$39.71M | -$38.02M | -$37.51M | -$20.88M | |
| — | -$7.58M | -$6.96M | -$32K | -$81K | $2.39M | $1.43M | $104K | $640K | $215K | |
| — | -$43.74M | -$51.06M | -$84.6M | -$78.5M | -$75.21M | -$41.14M | -$38.12M | -$38.15M | -$21.1M | |
| — | — | -24.19% | -50.95% | -47.53% | -46.51% | -32.47% | -45.02% | -42.59% | -34.47% | |
| — | -$44.53M | -$53.19M | -$83.27M | -$79.25M | -$76.15M | -$40.36M | -$35.94M | -$37.91M | -$20.73M | |
| USD/shares | — | — | -$1.72 | -$3.00 | -$3.07 | -$3.08 | -$1.72 | — | — | — |
| USD/shares | — | — | -$1.72 | -$3.00 | -$3.07 | -$3.08 | -$1.72 | — | — | — |
| shares | — | — | 29.62M | 28.16M | 25.6M | 24.46M | 23.97M | 23.32M | 20.54M | 17.35M |
| shares | — | — | 29.62M | 28.16M | 25.6M | 24.46M | 23.97M | 23.32M | 20.54M | 17.35M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.14×
EV/EBIT
—
Medical Devices median 21.36×
P/E (TTM)
—
Medical Devices median 27.81×
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| EMEA | $91,052,000 | $78,209,000 | $80,150,000 | $62,419,000 | $57,913,000 | — | — |
| North America | $45,557,000 | $4,410,000 | $2,157,000 | $995,000 | — | — | — |
| Latin America | $39,926,000 | $34,998,000 | $48,891,000 | $52,442,000 | $38,226,000 | $21,512,000 | $27,994,000 |
| Asia Pacific | $34,541,000 | $48,408,000 | $33,953,000 | $45,844,000 | $29,677,000 | — | — |
| Asia Pacific and Middle East | — | — | — | — | — | $24,986,000 | $24,819,000 |
| Other Geographical Areas | — | — | — | — | $866,000 | $511,000 | $540,000 |
| Europe | — | — | — | — | — | $37,667,000 | $36,212,000 |
Key facts
CIK
1688757
CUSIP
G31249108
13F (30d)
15 filings
15 filers
Visit website
Investor relations